Menu
GWAS Study

Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.

Gudmundsson J, Sigurdsson JK, Stefansdottir L et al.

30410027 PubMed ID
GWAS Study Type
301162 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

GJ
Gudmundsson J
SJ
Sigurdsson JK
SL
Stefansdottir L
AB
Agnarsson BA
IH
Isaksson HJ
SO
Stefansson OA
GS
Gudjonsson SA
GD
Gudbjartsson DF
MG
Masson G
FM
Frigge ML
SS
Stacey SN
SP
Sulem P
HG
Halldorsson GH
TV
Tragante V
HH
Holm H
EG
Eyjolfsson GI
SO
Sigurdardottir O
OI
Olafsson I
JT
Jonsson T
JE
Jonsson E
BR
Barkardottir RB
HR
Hilmarsson R
AF
Asselbergs FW
GG
Geirsson G
TU
Thorsteinsdottir U
RT
Rafnar T
TG
Thorleifsson G
SK
Stefansson K
Chapter II

Abstract

Summary of the research findings

Benign prostatic hyperplasia and associated lower urinary tract symptoms (BPH/LUTS) are common conditions affecting the majority of elderly males. Here we report the results of a genome-wide association study of symptomatic BPH/LUTS in 20,621 patients and 280,541 controls of European ancestry, from Iceland and the UK. We discovered 23 genome-wide significant variants, located at 14 loci. There is little or no overlap between the BPH/LUTS variants and published prostate cancer risk variants. However, 15 of the variants reported here also associate with serum levels of prostate specific antigen (PSA) (at a Bonferroni corrected P < 0.0022). Furthermore, there is a strong genetic correlation, rg = 0.77 (P = 2.6 × 10-11), between PSA and BPH/LUTS, and one standard deviation increase in a polygenic risk score (PRS) for BPH/LUTS increases PSA levels by 12.9% (P = 1.6×10-55). These results shed a light on the genetic background of BPH/LUTS and its substantial influence on PSA levels.

20,621 European ancestry cases, 280,541 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

301162
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Iceland, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.